Last reviewed · How we verify

NCT05079802: LSTR

Clinical & Radiographic Evaluation of LSTR in Non-vital Primary Molars Using Two Different Vehicles

Status unknown Phase 3 Last updated 8 November 2021
What this trial tests

Phase 3 trial testing Double antibiotic paste mixed with chitosan nanoparticles in Resorption of Tooth or Root in 36 participants. Status unknown.

Timeline
1 December 2021
Primary endpoint
31 December 2023
31 March 2024

Quick facts

Lead sponsorAin Shams University
PhasePhase 3
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment36
Start date1 December 2021
Primary completion31 December 2023
Estimated completion31 March 2024

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 4 to 7, any sex, with Resorption of Tooth or Root. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

LSTR will be done for primary teeth with significant root resorption needing non-vital pulp therapy to save such teeth for up to 12 months. The first part will be in vitro study to compare the antimicrobial effect of double antibiotic paste mixed with chitosan nanoparticle vs double antibiotic paste mixed with propylene glycol. The second part will be randomized clinical trial comparing the clinical and radiographic success of LSTR in study group where double antibiotic mix is mixed with chitosan nanoparticles and control group where double antibiotic paste is mixed with propylene glycol .

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Nanomaterials-Based Combinatorial Therapy as a Strategy to Combat Antibiotic Resistance.
    León-Buitimea A, Garza-Cárdenas CR, Román-García MF, Ramírez-Díaz CA, et al · · 2022 · cited 23× · PMID 35740200 · DOI 10.3390/antibiotics11060794
  2. Applications of Chitosan in Prevention and Treatment Strategies of Infectious Diseases.
    Sinani G, Sessevmez M, Şenel S. · · 2024 · cited 16× · PMID 39339237 · DOI 10.3390/pharmaceutics16091201
  3. Chitosan Micro/Nanocapsules in Action: Linking Design, Production, and Therapeutic Application.
    Pérez-Pacheco Y, Tylkowski B, García-Valls R. · · 2025 · cited 12× · PMID 39860124 · DOI 10.3390/molecules30020252

Verify or expand the search:

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05079802.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing